课题基金 / 基金详情

BIOLOGY OF NON-A, NON-B HEPATITIS AGENTS

BIOLOGY OF NON-A, NON-B HEPATITIS AGENTS
非甲型、非乙型肝炎病原体的生物学
批准号:
3818186
负责人:
S M FEINSTONE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

S M FEINSTONE的其他基金

相似基金

相关文献

中文摘要
翻译
凯龙公司的迈克尔霍顿和同事克隆了, 表达并测序NANBH基因组的至少一部分, 剂 他们认为这是一个10KB的正义多聚腺苷酸化的 可能与α披膜病毒有关的RNA病毒。 序列 在NANBH部分序列和 任何其他已知的病毒序列 我计划用各种各样的cDNA 克隆程序,以确认凯龙发现。 然而,由于他们开始使用升数量的血浆, 每毫升含有106个传染性病毒,我有大约100个 毫升血浆的相同滴度,任务很可能是非常 难 希望聚合酶链反应 技术将有助于这一努力。 非甲非乙型肝炎的分子鉴别方法 代理商现在涉及技术的开发, 克隆极少量的核酸。 我们知道 NANBH剂以非常低的水平存在于血清甚至肝脏中, 也就是说,低于106感染单位/ml血清或克 肝脏 如果产生poly(A)+NANBHmRNA, 是非常低丰度的信息。 因此,无论是直接克隆 DNA或cDNA克隆在技术上是非常困难的。 为了 辅助克隆少量DNA或cDNA,即"不可克隆的" 一段RNA或DNA已经产生。 这个不可克隆的片段 将被添加到NANBH核酸制剂中, 用于所有克隆步骤的载体。 这个不可克隆的片段将被 适用于许多不同的克隆策略, 目的核酸的含量非常低。
英文摘要
Michael Houghton and colleagues at Chiron Corporation have cloned, expressed and sequenced at least part of the genome of the NANBH agent. They believe it is a 10KB, positive sense polyadenylated RNA virus that may be related to the alpha togaviruses. Sequence homology has not been found between the NANBH partial sequence and any other known viral sequence. I plan to use a variety of cDNA cloning procedures in order to confirm the Chiron findings. However, since they started with liter quantities of plasma that contained 106 infectious viruses/ml and I have approximately 100 ml of plasma of the same titer, the task is likely to be very difficult. It is hoped that the polymerase chain reaction technique will aid this effort. Molecular approaches to identifying the non-A, non-B hepatitis agent now involve development of technology that can be used to clone extremely small quantities of nucleic acid. We know that the NANBH agent is present in serum and even liver at very low levels, i.e., less than 106 infectious units per ml of serum or gram of liver. It also seems that if poly(A)+NANBH mRNA is produced, it is a very low abundance message. Therefore, either direct cloning of DNA or cDNA cloning is technically very difficult. In order to assist cloning small quantities of DNA or cDNA, a "nonclonable" piece of RNA or DNA has been produced. This non-clonable fragment will be added to NANBH nucleic acid preparations to act as a carrier for all cloning steps. This non-clonable fragment will be useful for a number of different cloning strategies where the level of the nucleic acid of interest is very low.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HYBRIDOMA ANTIBODIES TO PATHOGENIC VIRUSES
HEPATITIS C VIRUS NEUTRALIZATION METHOD DEVELOPMENT
  • 批准号:
    6101194
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    S M FEINSTONE
  • 依托单位:
    --
STRUCTURAL AND ANTIGENIC ANALYSIS OF HEPATITIS A VIRUS
ANTIGENIC STRUCTURE OF HEPATITIS A VIRUS
  • 批准号:
    3811272
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    S M FEINSTONE
  • 依托单位:
    --
海外基金